Stephens Inc Eli Lilly & CO Transaction History

Stephens Inc

$6.31 Billion
Q2 2024

A detailed history of Stephens Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Stephens Inc holds 52,450 shares of LLY stock, worth $47.9 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

52,450

Previous 34,413 52.41%

Holding current value

$47.9 Million

Previous $26.8 Million 77.38%

% of portfolio

0.75%

Previous 0.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $13.1 Million - $16.4 Million	18,037 Added 52.41%	52,450 $47.5 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $2.3 Million - $3.08 Million	3,885 Added 12.73%	34,413 $26.8 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $268,897 - $316,994	512 Added 1.71%	30,528 $17.8 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $166,924 - $230,131	384 Added 1.3%	30,016 $16.1 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $35,424 - $47,366	-101 Reduced 0.34%	29,632 $13.9 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $784,340 - $921,170	-2,525 Reduced 7.83%	29,733 $10.2 Million
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $249,201 - $290,369	-775 Reduced 2.35%	32,258 $11.8 Million
Q3 2022 Nov 02, 2022	SELL	$296.48 - $337.87 $119,481 - $136,161	-403 Reduced 1.21%	33,033 $10.7 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $2.95 Million - $3.46 Million	10,581 Added 46.3%	33,436 $10.8 Million
Q1 2022 May 04, 2022	SELL	$234.69 - $291.66 $1.19 Million - $1.48 Million	-5,068 Reduced 18.15%	22,855 $6.55 Million
Q4 2021 Mar 07, 2022	SELL	$224.85 - $279.04 $37,549 - $46,599	-167 Reduced 0.59%	27,923 $7.71 Million
Q3 2021 Oct 27, 2021	SELL	$221.6 - $272.71 $15,068 - $18,544	-68 Reduced 0.24%	28,090 $6.49 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $731,769 - $946,537	4,053 Added 16.81%	28,158 $6.46 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $236,292 - $305,891	-1,438 Reduced 5.63%	24,105 $4.5 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $203,256 - $268,957	-1,558 Reduced 5.75%	25,543 $4.31 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $536,919 - $621,045	-3,672 Reduced 11.93%	27,101 $4.01 Million
Q2 2020 Aug 24, 2020	SELL	$136.42 - $164.18 $430,405 - $517,987	-3,155 Reduced 9.3%	30,773 $5.05 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $183,456 - $227,066	-1,541 Reduced 4.34%	33,928 $4.71 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $743,094 - $920,388	-6,950 Reduced 16.38%	35,469 $4.66 Million
Q3 2019 Oct 18, 2019	BUY	$106.79 - $116.16 $637,536 - $693,475	5,970 Added 16.38%	42,419 $4.74 Million
Q2 2019 Aug 01, 2019	SELL	$110.79 - $129.32 $519,161 - $605,993	-4,686 Reduced 11.39%	36,449 $4.04 Million
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $290,741 - $342,224	-2,612 Reduced 5.97%	41,135 $5.34 Million
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $150,272 - $168,350	-1,419 Reduced 3.14%	43,747 $5.06 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $48,596 - $60,737	566 Added 1.27%	45,166 $4.85 Million
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $19,152 - $21,980	253 Added 0.57%	44,600 $3.81 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $398,878 - $470,849	5,375 Added 13.79%	44,347 $3.43 Million
Q4 2017 Feb 05, 2018	SELL	$81.94 - $87.89 $329,398 - $353,317	-4,020 Reduced 9.35%	38,972 $3.29 Million
Q3 2017 Nov 08, 2017	SELL	$77.07 - $85.54 $207,472 - $230,273	-2,692 Reduced 5.89%	42,992 $3.68 Million
Q2 2017 Aug 10, 2017	BUY	N/A	45,684	45,684 $3.76 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $867B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account